About US
Contact us
-
Latin America’s medical cannabis market to reach $8.5bn by 2028Research consultancy Prohibition Partners has predicted that medical cannabis will account for approximately two-thirds of the total value of Latin America’s cannabis market by 2028 in its first Latin2018/10/11
-
Janssen reports positive data of Stelara drug from UNIFI trialJanssen Pharmaceutical has reported positive eight-week induction data from Phase III UNIFI clinical trial of Stelara (ustekinumab) for the treatment of adults with moderate to severe ulcera2018/10/11
-
The First FDA-approved Digital Pill — What It Means for PharmaLast year, the U.S. Food and Drug Administration (FDA) approved what is perhaps the boldest use of digital technology in healthcare: a pill that is integrated with an ingestible sensor that captures i2018/10/10
-
Litigation teaches Chinese valsartan maker the downside of U.S. marketChina’s Zhejiang Huahai Pharmaceutical for years enjoyed the upside of the U.S. pharmaceutical market, selling its valsartan API to drugmakers producingblood pressure meds for the market. Now it is se2018/10/10
-
FDA approves use of Merck’s HPV vaccine for up to age 45The US Food and Drug Administration (FDA) has approved the use of Merck’s Gardasil 9 HPV vaccine in adults aged from 27 to 45 years. Gardasil 9 is indicated for the prevention of certain cancers and2018/10/9
-
NHS England reaches deal with Gilead on CAR-T therapy YescartaNational Health Service (NHS) England has reached an agreement with Gilead Sciences to provide the pharmaceutical company’s chimeric antigen receptor T-cell (CAR-T) therapy Yescarta (axicabtagene cilo2018/10/9
-
Janssen signs $3.7bn licence agreements with ArrowheadJanssen Pharmaceuticals has signed a $3.7bn licence and collaboration agreement with Arrowhead Pharmaceuticals for the development and commercialisation of a new therapy candidate, ARO-HBV. ARO-HBV i2018/10/8
-
Vertex’s cystic fibrosis drugs become publicly available in DenmarkVertex Pharmaceuticals has signed an access agreement with Denmark’s pharmaceutical procurement agency Amgros for public hospital use of all current and future drugs for mutations in the cystic fibros2018/10/8
-
EMA, MHRA and GlaxoSmithKline blast BMJ’s ‘flawed’ pandemic flu vaccine safety reportEuropean drug regulatory bodies and GlaxoSmithKline have quickly rallied their rebuttals to a BMJ report that questioned the safety profile of GSK’s now-unavailable pandemic flu vaccine Pandemrix, as2018/9/30
-
Pfizer's once-failed Vizimpro rebounds with targeted lung cancer approvalIt’s been a long road for Pfizer’s dacomitinib, but the targeted lung cancer drug final has an FDA green light. Late Thursday, the agencyhandedPfizer an OK for the cancer-fighter, which will bear the2018/9/30